Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (541-550 of 567) with videos related to

Pageof 57
Sort By:
The American Journal of Cardiology|April 15, 1996
A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II InvestigatorsC M O'Connor, R B Meese, S McNulty, et al.
Circulation|September 7, 2000
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial InvestigatorsM T Roe, R A Harrington, D M Prosper, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Journal of the American College of Cardiology|February 24, 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT InvestigatorsA B Greenbaum, R A Harrington, M P Hudson, et al.
Circulation|June 9, 1999
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experienceM W McClure, S D Berkowitz, R Sparapani, et al.
The American Journal of Medicine|November 4, 2000
Redefining medical treatment in the management of unstable anginaE Braunwald, R M Califf, C P Cannon, et al.
Annals of Internal Medicine|February 1, 1995
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatmentsW A Knaus, F E Harrell, J Lynn, et al.
Circulation|September 7, 2000
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialA M Lincoff, R A Harrington, R M Califf, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Circulation|May 11, 1999
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT InvestigatorsK W Mahaffey, R A Harrington, M L Simoons, et al.
Pageof 57

Showing results (541-550 of 567) with videos related to

Sort By:
Pageof 57
The American Journal of Cardiology|April 15, 1996
A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II InvestigatorsC M O'Connor, R B Meese, S McNulty, et al.
Circulation|September 7, 2000
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial InvestigatorsM T Roe, R A Harrington, D M Prosper, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Journal of the American College of Cardiology|February 24, 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT InvestigatorsA B Greenbaum, R A Harrington, M P Hudson, et al.
Circulation|June 9, 1999
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experienceM W McClure, S D Berkowitz, R Sparapani, et al.
The American Journal of Medicine|November 4, 2000
Redefining medical treatment in the management of unstable anginaE Braunwald, R M Califf, C P Cannon, et al.
Annals of Internal Medicine|February 1, 1995
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatmentsW A Knaus, F E Harrell, J Lynn, et al.
Circulation|September 7, 2000
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialA M Lincoff, R A Harrington, R M Califf, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Circulation|May 11, 1999
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT InvestigatorsK W Mahaffey, R A Harrington, M L Simoons, et al.
Pageof 57